Profile data is unavailable for this security.
About the company
Shenzhen Lifotronic Technology Co Ltd is a China-based company mainly engaged in the research, development, manufacturing and marketing of medical devices. The Company focuses on the development and technological innovation of treatment and rehabilitation equipment, in vitro diagnostic equipment and supporting detection reagents. The Company's products mainly include wound and skin treatment products, perioperative and intensive care products, pain and rehabilitation treatment products and in vitro diagnostic products. The Company mainly conducts its businesses in domestic and overseas markets.
- Revenue in CNY (TTM)1.19bn
- Net income in CNY381.08m
- Incorporated2008
- Employees1.48k
- LocationShenzhen Lifotronic Technology Co Ltd4F, Building 15No. 1008, Xili Songbai RoadNanshan DistrictShenzhen 518000ChinaCHN
- Phone+86 75 529060052
- Fax+86 75 529060036
- Websitehttp://www.lifotronic.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innovita Biological Technology Co Ltd | 720.40m | 332.01m | 5.82bn | 404.00 | 17.46 | 2.85 | -- | 8.07 | 2.44 | 2.44 | 5.30 | 14.98 | 0.3584 | 3.18 | 9.16 | 1,783,177.00 | 16.52 | -- | 17.42 | -- | 80.70 | -- | 46.09 | -- | 16.01 | -- | 0.001 | -- | 7.03 | -- | 15.44 | -- | -- | -- |
| Zhende Medical Co Ltd | 4.04bn | 205.34m | 6.17bn | 6.72k | 30.14 | 1.11 | -- | 1.53 | 0.7684 | 0.7684 | 15.19 | 20.95 | 0.5191 | 3.12 | 6.43 | 601,941.30 | 2.85 | 17.13 | 3.61 | 23.54 | 34.16 | 38.05 | 5.49 | 17.33 | 1.80 | 38.53 | 0.1465 | 29.85 | -32.76 | 23.63 | -70.87 | 8.79 | 21.46 | 47.58 |
| Zhejiang Orient Gene Biotech Co Ltd | 825.60m | -587.36m | 6.49bn | 2.23k | -- | 0.9432 | -- | 7.86 | -2.93 | -2.93 | 4.14 | 34.13 | 0.0949 | 1.17 | 3.19 | 370,058.00 | -7.18 | 29.62 | -8.27 | 38.29 | 39.26 | 59.69 | -75.73 | 35.82 | 3.71 | -- | 0.0744 | 19.24 | -90.65 | 23.46 | -119.23 | -- | 121.04 | -- |
| Shanghai Aohua Phtlctrcty Endscp Co Ltd | 750.04m | 49.97m | 6.92bn | 1.09k | 127.80 | 5.00 | -- | 9.23 | 0.4023 | 0.4023 | 5.56 | 10.27 | 0.4682 | 1.01 | 3.34 | 686,850.10 | 3.26 | 4.37 | 3.66 | 4.80 | 68.88 | 69.25 | 6.97 | 10.91 | 3.33 | -- | 0.0815 | 31.51 | 52.29 | 34.25 | 166.42 | -- | 20.42 | -- |
| Shenzhen Lifotronic Technology Co Ltd | 1.19bn | 381.08m | 7.06bn | 1.48k | 18.51 | 3.62 | -- | 5.92 | 0.8909 | 0.8909 | 2.79 | 4.55 | 0.4834 | 2.27 | 7.49 | 805,792.80 | 15.37 | 13.82 | 21.09 | 16.33 | 67.06 | 61.01 | 31.79 | 26.10 | 2.25 | -- | 0.2434 | 41.51 | 16.55 | 28.78 | 30.66 | 32.27 | -7.91 | -- |
| HOB Biotech Group Corp Ltd | 401.29m | 35.26m | 7.76bn | 550.00 | 219.11 | 9.50 | -- | 19.33 | 0.5614 | 0.5614 | 6.35 | 12.95 | 0.4102 | 1.37 | 8.23 | 729,609.80 | 3.60 | 9.94 | 4.33 | 12.10 | 61.87 | 65.30 | 8.79 | 19.53 | 0.9438 | 39.42 | 0.1192 | 32.59 | 23.10 | 14.38 | 13.64 | 3.34 | 46.19 | -- |
Data as of Nov 15 2024. Currency figures normalised to Shenzhen Lifotronic Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
14.59%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 28.63m | 6.73% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 7.98m | 1.88% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2024 | 6.00m | 1.41% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 4.91m | 1.15% |
| Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 2024 | 4.79m | 1.13% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2024 | 2.90m | 0.68% |
| Truvalue Asset Management Co. Ltd.as of 30 Jun 2024 | 2.42m | 0.57% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 1.95m | 0.46% |
| China International Capital Corp. Ltd. (Invt Management)as of 30 Jun 2024 | 1.30m | 0.31% |
| Morgan Stanley Huaxin Fund Management Co., Ltd.as of 30 Jun 2024 | 1.21m | 0.28% |
More ▼
Data from 30 Jun 2024 - 27 Sep 2024Source: FactSet Research Systems Inc.
